The Young Stroke Physicians and Researchers (YSPR) Committee, composed of young members of the European Stroke Organisation, is dedicated to promoting the involvement of young stroke physicians and researchers in the ESO and the broader field of stroke care. On behalf of the YSPR, Dr Sarah Gorey highlights some key challenges in stroke-related care, as well as recent innovations in treatment.
Samantha Benham-Hermetz, Director of Policy and Public Affairs at Alzheimer’s Research UK charts us through the priorities for dementia research in the UK in light of COVID-19.
Daniel Berman from Nesta Challenges and Colin Capper at the Alzheimer’s Society focus here on dementia tech, including comment on overcoming barriers to innovation post-pandemic.
Dementia UK’s Head of Research and Publications, Dr Karen Harrison Dening, discusses her thoughts on the diagnosis of dementia and the impact of COVID-19 on this.
Over 12 US Immigration and Customs Enforcement (ICE) detention centres had multiple outbreaks of infectious disease - due to withholding vaccines for adult and child migrants.
Professor Martin Michaelis and Dr Mark Wass of University of Kent’s School of Biosciences, explain why a herd immunity approach to COVID-19 would include great risk, potentially many deaths, and may simply not work.
Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.
Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
